[ad_1]
The drugmaker is pulling back on some of its research programs and laying off workers after overestimating pandemic-product sales.
[ad_2]
Source link
[ad_1]
The drugmaker is pulling back on some of its research programs and laying off workers after overestimating pandemic-product sales.
[ad_2]
Source link